The Honorable Jim Greenwood discusses the art and science of multi-stakeholder collaborations

Read More
Development Of A Unified Clinical Trial Database For Alzheimer’s Disease Neville J, Kopko S, Broadbent S, Avilés E, Stafford R, Solinsky CM, Bain LJ, Cisneroz M, Romero K, Stephenson D, Coalition Against Major Diseases. Development Of A Unified Clinical Trial Database For Alzheimer’s Disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. 2015 Feb 9.
Perspectives on Best Practices for Gene Therapy Programs Cheever TR, Berkley D, Braun S, Brown RH, Byrne BJ, Chamberlain JS, Cwik V, Duan D, Federoff HJ, High KA, Kaspar BK, Klinger KW, Larkindale J, Lincecum J, Mavilio F, McDonald CL, McLaughlin J, Weiss McLeod B, Mendell JR, Nuckolls G, Stedman HH, Tagle DA, Vandenberghe LH, Wang H, Wernett PJ, Wilson JM, Porter JD, Gubitz AK. Perspectives on Best Practices for Gene Therapy Programs. Human Gene Therapy. 2015 Mar;26(3):127–33.
The Choice of Outcome Parameters and Need for Distinct Assessment Tools with Regard to the Different Disease Stages in Alzheimer’s Disease (Video)

Brumfield M on behalf of the Coalition Against Major Diseases program. The Choice of Outcome Parameters and Need for Distinct Assessment Tools with Regard to the Different Disease Stages in Alzheimer’s Disease. European Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer's disease; 2014 November 24-25; London, UK.